Picture of virus

Open Access research that helps to deliver "better medicines"...

Strathprints makes available scholarly Open Access content by the Strathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS), a major research centre in Scotland and amongst the UK's top schools of pharmacy.

Research at SIPBS includes the "New medicines", "Better medicines" and "Better use of medicines" research groups. Together their research explores multidisciplinary approaches to improve understanding of fundamental bioscience and identify novel therapeutic targets with the aim of developing therapeutic interventions, investigation of the development and manufacture of drug substances and products, and harnessing Scotland's rich health informatics datasets to inform stratified medicine approaches and investigate the impact of public health interventions.

Explore Open Access research by SIPBS. Or explore all of Strathclyde's Open Access research...

Mesenchymal stem cell fate : applying biomaterials for control of stem cell behavior

Anderson, Hilary J. and Sahoo, Jugal Kishore and Ulijn, Rein V. and Dalby, Matthew J. (2016) Mesenchymal stem cell fate : applying biomaterials for control of stem cell behavior. Frontiers in Bioengineering and Biotechnology, 4. ISSN 2296-4185

[img]
Preview
Text (Anderson-etal-FBB2016-Mesenchymal-stem-cell-fate-applying-biomaterials)
Anderson_etal_FBB2016_Mesenchymal_stem_cell_fate_applying_biomaterials.pdf
Final Published Version
License: Creative Commons Attribution 4.0 logo

Download (1MB) | Preview

Abstract

The materials pipeline for biomaterials and tissue engineering applications is under continuous development. Specifically, there is great interest in the use of designed materials in the stem cell arena as materials can be used to manipulate the cells providing control of behaviour. This is important as the ability to 'engineer' complexity and subsequent in vitro growth of tissues and organs is a key objective for tissue engineers. This review will describe the nature of the materials strategies, both static and dynamic, and their influence specifically on mesenchymal stem cell fate.